Cerenome (CNSY) vs SiNtx Technologies (SINT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SiNtx Technologies (SINT) has outperformed Cerenome (CNSY) over the past year, losing 53.3% versus a loss of 90.5%. Over five years, CNSY leads with a -99.7% price change compared with -100.0% for SINT. SiNtx Technologies is the larger company by market cap ($14.1 million vs $13.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNSY | SINT |
|---|---|---|
| Share price | $1.79 | $2.11 |
| Market cap | $13.59M | $14.06M |
| 1-day change | +9.48% | -2.76% |
| YTD return | -85.96% | -45.34% |
| 1-year return | -90.45% | -53.32% |
| 5-year return | -99.73% | -99.99% |
| EPS (TTM) | $-3.36 | $-4.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.00 | $4.64 |
| 52-week low | $1.49 | $1.40 |
| Distance from 52-week high | -90.58% | -54.53% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +1450.28% | +338.39% |
| Average volume | 121.12K | 112.93K |
| Shares outstanding | 7.59M | 6.66M |
| Employees | 28 | 32 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SINT has outperformed CNSY by 37.1 percentage points over the past year.
About Cerenome
CNSY stock →Cerenome, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers.
Health Care · Medical/Dental Instruments · 28 employees
About SiNtx Technologies
SINT stock →Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE).
Health Care · Medical/Dental Instruments · 32 employees
CNSY vs SINT FAQ
Which is bigger, Cerenome or SiNtx Technologies?
SiNtx Technologies (SINT) is larger, with a market capitalization of $14.06M compared with $13.59M for Cerenome (CNSY).
Which stock has performed better over the past year, CNSY or SINT?
SINT returned -53.32% over the past 12 months, compared with -90.45% for CNSY (price return, excluding dividends). Past performance does not predict future results.
Are Cerenome and SiNtx Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.